Revance Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8M | 2.0M | 0.88 |
| 2023-09-30 | $1.8M | 2.0M | 0.88 |
| 2021-03-31 | $390k | 348k | 1.12 |